Optics News

Orasis Pharmaceuticals announced that its phase 3 trials showed patients treated with CSF-1 achieved a statistically significant three-line or more gain in distance-corrected near visual acuity with no loss of distance visual acuity.

In a company release, Horizon Therapeutics announced results from a phase 2/3 trial demonstrating that its B-cell-depleting agent Uplizna reduced the severity of attacks in people with neuromyelitis optica spectrum disorder.

ORLANDO — In this Healio Video Perspective from Cataract Surgery: Telling It Like It Is, I. Paul Singh, MD, discusses a presbyopia-correcting drop in development by Ocuphire and its unique mechanism of action.

ORLANDO — With the recent approval of Allergan’s Vuity presbyopia-correcting eye drop, many patients have been asking their ophthalmologists about the drop’s availability and effectiveness, and a panel discussed their experience here.

Neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein-antibody associated disease incur significant costs for individuals, their families and for society, according to study results published in Neurology.

Uplizna appeared to benefit patients with neuromyelitis optica spectrum disorder who were previously treated with rituximab, according to study results published in Multiple Sclerosis and Related Disorders.

A smartphone application may help clinicians detect concussion biomarkers, according to study results published in Life.

Vision impairment may increase risk for future depressive symptoms among women during midlife, according to study results published in Menopause: The Journal of The North American Menopause Society.

Noel A. Brennan, MScOptom, PhD, FAAO, presented a poster at this year’s ARVO virtual meeting that focused on the increasing prevalence of high myopia even among adults that may affect disease rates in the near future.

Spectacle lenses with aspheric lenslets, also known as the Essilor Stellest lenses, were found to significantly slow myopia progression and axial elongation in children, according to results from a 2-year clinical trial presented at the virtual Association for Research in Vision and Ophthalmology meeting.